Galectin Therapeutics, Inc. (GALT)
3.385
+0.20
(+6.11%)
USD |
NASDAQ |
Oct 27, 16:00
3.385
0.00 (0.00%)
After-Hours: 16:26
Galectin Therapeutics Total Return Level : 3.19 for Oct. 26, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 26, 2026 | 3.19 |
| October 23, 2026 | 3.19 |
| October 22, 2026 | 3.38 |
| October 21, 2026 | 3.37 |
| October 20, 2026 | 3.43 |
| October 19, 2026 | 3.495 |
| October 16, 2026 | 3.62 |
| October 15, 2026 | 3.71 |
| October 14, 2026 | 3.64 |
| October 13, 2026 | 3.69 |
| October 12, 2026 | 3.87 |
| October 09, 2026 | 3.94 |
| October 08, 2026 | 3.64 |
| October 07, 2026 | 3.62 |
| October 06, 2026 | 3.76 |
| October 05, 2026 | 3.73 |
| October 02, 2026 | 3.90 |
| October 01, 2026 | 3.76 |
| September 30, 2026 | 3.88 |
| September 29, 2026 | 3.91 |
| September 28, 2026 | 3.93 |
| September 25, 2026 | 3.90 |
| September 24, 2026 | 3.96 |
| September 23, 2026 | 4.05 |
| September 22, 2026 | 4.14 |
| Date | Value |
|---|---|
| September 21, 2026 | 3.96 |
| September 18, 2026 | 3.89 |
| September 17, 2026 | 3.71 |
| September 16, 2026 | 3.68 |
| September 15, 2026 | 3.73 |
| September 14, 2026 | 3.84 |
| September 11, 2026 | 3.91 |
| September 10, 2026 | 3.90 |
| September 09, 2026 | 4.05 |
| September 08, 2026 | 4.14 |
| September 04, 2026 | 4.61 |
| September 03, 2026 | 4.35 |
| September 02, 2026 | 4.48 |
| September 01, 2026 | 4.17 |
| August 31, 2026 | 3.95 |
| August 28, 2026 | 4.02 |
| August 27, 2026 | 4.14 |
| August 26, 2026 | 4.15 |
| August 25, 2026 | 3.99 |
| August 24, 2026 | 3.88 |
| August 21, 2026 | 3.68 |
| August 20, 2026 | 3.57 |
| August 19, 2026 | 3.67 |
| August 18, 2026 | 3.52 |
| August 17, 2026 | 3.51 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Mirum Pharmaceuticals, Inc. | 83.27 |
| ACADIA Pharmaceuticals, Inc. | 19.74 |
| Alnylam Pharmaceuticals, Inc. | 227.66 |
| Anika Therapeutics, Inc. | 21.27 |
| Savara, Inc. | 4.52 |